Both serous BOTs [39] and a subset of thyroid gland cancers [40] are associated with BRAF mutations; thus, there is a possibility that women with serous BOTs who subsequently develop thyroid gland cancer may have BRAF mutations. This evidence concerns the gene BRAF and thyroid cancer.